NCT02281643View on ClinicalTrials.gov

Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 15, 2017

Study Completion Date

March 15, 2017

Conditions
Mansonella Perstans InfectionBuruli UlcerTuberculosisCo-infection
Interventions
DRUG

Doxycycline

200mg oral doxycycline will be administered immediately (early) in the experimental arm or delayed in the comparator arm

Trial Locations (1)

Unknown

Agogo Presbyterian Hospital, Agogo

All Listed Sponsors
collaborator

University of Bonn

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

lead

Kwame Nkrumah University of Science and Technology

OTHER

NCT02281643 - Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana | Biotech Hunter | Biotech Hunter